COGNNA Raises $9.2 Million to Expand AI-Powered Cybersecurity Solutions Globally
Saudi Arabian cybersecurity startup COGNNA has secured $9.2 million in a Series A funding round, paving the way for significant global expansion. The round was spearheaded by Impact46, with co-leadership from BNVT Capital and participation from Vision Ventures and Tali Ventures. This substantial investment underscores the growing importance of advanced cybersecurity solutions in the face of increasingly sophisticated threats.
# Accelerating Growth and AI Capabilities
Founded in 2022 by Ibrahim Alshamrani and Ziyad Alshehri, COGNNA leverages artificial intelligence and sophisticated data analysis to proactively identify and mitigate threats within its clients’ systems and networks. The newly acquired capital will be strategically allocated to fuel product development, expand sales operations, enhance overall operations, and grow the team. A key focus will also be on advancing the company’s AI capabilities and scaling its Agentic SOC platform, offering cutting-edge threat detection and response. This follows a $2.25 million seed round in 2023, also led by Impact46, demonstrating continued investor confidence in COGNNA’s vision.
This Series A funding marks a significant milestone for COGNNA, positioning the company to further disrupt the cybersecurity landscape with its innovative AI-driven solutions. By expanding its global footprint and refining its technological prowess, COGNNA aims to provide enhanced protection against evolving cyber threats for organizations worldwide.
Keywords
Related Keywords: COGNNA funding, COGNNA Series A, AI drug discovery, drug discovery funding, pharmaceutical AI, AIpowered drug development, healthcare AI, global expansion, AI startup funding, 92 million funding
